logo
#

Latest news with #GuidetoInvesting

Cramer's Lightning Round: Starbucks is a buy
Cramer's Lightning Round: Starbucks is a buy

CNBC

time5 hours ago

  • Business
  • CNBC

Cramer's Lightning Round: Starbucks is a buy

Granite Construction: "I've always felt that GVA was a takeover target...I think that the infrastructure play is still on, and therefore Granite is still on." Solid Power: "Take a little off the table because that thing has just been a horse." Enovix: "We have a glut of oil. I'm worried about that. ENVX is another stock that is just up way too not going to buy that stock." General Mills: "...I am on the camp which says you can buy it because of the dividend, but not because the earnings. That's a tough one." Starbucks: "I would tell them to buy some now, the stock is down. That is the way to go. [buy, buy, buy]." Click here to download Jim Cramer's Guide to Investing at no cost to help you build long-term wealth and invest The CNBC Investing Club's Charitable Trust owns shares of Starbucks.

Jim Cramer names stocks hyped up by retail investors that are set to keep running
Jim Cramer names stocks hyped up by retail investors that are set to keep running

CNBC

time5 hours ago

  • Business
  • CNBC

Jim Cramer names stocks hyped up by retail investors that are set to keep running

CNBC's Jim Cramer on Monday listed four stocks he thinks have momentum, powered by excitement from retail investors — Palantir, AppLovin, Robinhood and Coinbase — dubbing the group "PARC." "These PARC names are emblematic of how stocks have devolved into a two-track market," he said. "There's the S&P 500, and then there's this handful of stocks that retail investors have anointed and relentlessly taken up, without any real bounds." Cramer conceded that these stocks pulled back and "took a breather" during Monday's session, but he said they're likely to bounce back. These companies are the best of a group of more trendy names that have caught the attention of a number of retail investors, Cramer said, because they seem to have solid earnings and attention from analysts. However, he suggested that metric doesn't seem to matter much to buyers, some of whom are "irrational believers in these companies." A number of retail investors are especially interested in stocks related to quantum computing, cryptocurrency and rockets, Cramer continued. He named outfits including Strategy, Oklo, Rocket Lab, Rigetti Computing, QuantumScape, Joby Aviation and Circle Internet. According to Cramer, investors can pick some of these stocks to own "as long as you don't flood the zone with them." There is money to be made in these names, he continued, but it's important that investors exercise discipline and "take something off the table" when they reap a big gain. "Aside from occasional pit stops like today, the PARC stocks just keep running," he said. "And until we see a wave of new IPOs creating a supply glut and a ton of insider selling, I wouldn't be surprised if they continue to rally." Click here to download Jim Cramer's Guide to Investing at no cost to help you build long-term wealth and invest

Cleveland-Cliffs CEO says surge in domestic auto manufacturing is imminent
Cleveland-Cliffs CEO says surge in domestic auto manufacturing is imminent

CNBC

time6 hours ago

  • Automotive
  • CNBC

Cleveland-Cliffs CEO says surge in domestic auto manufacturing is imminent

Cleveland-Cliffs CEO Lourenco Goncalves told CNBC's Jim Cramer on Monday that domestic auto production will ramp up. "In this country, we have eight finishing facilities ready to go. We are ready for the surge that we're going to have in automotive," Goncalves said. "And that's right now — not in two years, not in three years, not in five years. It's right now." Cleveland-Cliffs, which is one of the largest steel producers in the U.S., saw its stock begin to climb two months ago, after President Donald Trump announced he would double tariffs on foreign steel from 25% to 50%. According to Goncalves, Trump is "creating the foundation for a rebirth of manufacturing, particularly automotive." The company posted a better-than-expected quarter Monday morning, which sent shares up. By close, the stock had gained 12.45% and continued to rise in extended trading. Goncalves was critical of the Federal Reserve and its decision not to cut interest rates. He suggested that lower interest rates are necessary to boost the housing market, which he indicated is related to the auto market. He said he doesn't want a poor housing market to "start contaminating the automotive market" at a time when domestic production could heat up. Goncalves said auto manufacturing would be the main driver of his company's earnings growth. "The more we produce cars in the United States, the more we will be able to produce steel," he said. "Because you supply them, and with higher production, we dilute our fixed costs, our costs go down, our margins increase, and that's where my earnings power is." Click here to download Jim Cramer's Guide to Investing at no cost to help you build long-term wealth and invest

Jim Cramer explains why Johnson & Johnson rallied after 'surprise' earnings results
Jim Cramer explains why Johnson & Johnson rallied after 'surprise' earnings results

CNBC

time4 days ago

  • Business
  • CNBC

Jim Cramer explains why Johnson & Johnson rallied after 'surprise' earnings results

As Wall Street navigates a jam-packed start to earnings season, CNBC's Jim Cramer explained what made shares of Johnson & Johnson rise after the company posted its quarterly report. "Sometimes in this game, you do just get lucky," he said. "You'll come across a surprise quarter that tells you everything you need to know about what can cause a big cap stock to rally ten points in a session. You'll see how a star is born and even get a blueprint for what you need, what you should be looking for." Stock of the pharmaceutical giant climbed more than 6% during Wednesday's session after it beat on earnings and revenue. Cramer said the "storied company" has been weighed down for years by ongoing lawsuits that allege its talc products cause cancer. According to Cramer, it took "many surprises" to spur Johnson & Johnson's gains. He told investors it's worthwhile to review an "earnings scorecard slash schematic of what a winner looks like." Some fundamental data from the quarter helped fuel Johnson & Johnson's rally, Cramer said. The company beat on earnings and sales, and it managed to significantly raise guidance for both metrics. He also said pharma names like Johnson & Johnson need to relay breakthroughs in research — and the drug maker was able to share promising results from one of its newer cancer treatments. Right now, good news on the tariff front is attractive to investors, Cramer continued. He pointed out that Johnson & Johnson was able to cut its previous estimates for costs related to the new duties. Wall Street also appreciates when a new quarter shows that a previous issue has been remedied, Cramer said. Johnson & Johnson's med-tech division dragged shares down after the last quarter, he suggested. But this time, he said, the business didn't disappoint. Johnson & Johnson also impressed Wall Street with projections for the future, Cramer added, highlighting management's lofty assertion on the call that it would be "the number one oncology company by 2030 with sales of more than $50 billion." Cramer noted that the company announced a breakthrough in bladder cancer treatment that could be worth $5 billion in peak sales. "Check your stocks. Do they have a chance to change their stripes like J&J? Do they fit the formula?" he asked. "Then, you know what, you may be just sitting on – say it with me – a gold mine." Johnson and Johnson did not immediately respond to request for comment. Click here to download Jim Cramer's Guide to Investing at no cost to help you build long-term wealth and invest

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store